Skip to main content
Lewis Silverman, MD, Oncology, New York, NY, The Mount Sinai Hospital

LewisRSilvermanMD

Oncology • New York, NY

Hematologic Oncology

Associate Professor of Medicine, Mount Sinai School of Medicine

Request Appointment

Overview of Dr. Silverman

Dr. Lewis Silverman is an oncologist in New York, NY and is affiliated with The Mount Sinai Hospital. He received his medical degree from Universite Libre de Bruxelles Faculty of Medicine and has been in practice 39 years. Dr. Silverman accepts several types of health insurance, listed below. He is one of 191 doctors at The Mount Sinai Hospital who specialize in Oncology. He has more than 90 publications and over 500 citings.

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1983 - 1984
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1982 - 1983
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1980 - 1981
  • New York Medical College (Metropolitan)
    New York Medical College (Metropolitan)Residency, Internal Medicine, 1978 - 1980
  • Universite Libre de Bruxelles Faculty of Medicine
    Universite Libre de Bruxelles Faculty of MedicineClass of 1978

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1979 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2010-2014
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Phase 3, Multi-Center, International, Randomized, Double-Blind, Placebo Controlled Study of Oral Rigosertib + Injectable Azacitidine (AZA) Versus Injectable Azacitidin...
    Lewis R. Silverman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Phase 3, Multi-Center, International, Randomized, Double-Blind, Placebo Controlled Study of Oral Rigosertib + Injectable Azacitidine (AZA) Versus Injectable Azacitidin...
    Lewis R. Silverman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • T-Cell Mediated Cytopenias in Patients with Myelodysplastic Syndromes Respond to Intravenous Immunoglobulin
    Lewis R. Silverman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Truncation Products of Stromal Cell Derived Factor-1 (CXCL12) Quantified By Mass Spectrometry in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Advancements in the Treatment of Myelodysplastic Syndromes and RAS-Mutated Lung Cancers to Be Presented by Key Opinion Leaders on Thursday, February 7, 2019, in New York City
    Advancements in the Treatment of Myelodysplastic Syndromes and RAS-Mutated Lung Cancers to Be Presented by Key Opinion Leaders on Thursday, February 7, 2019, in New York CityJanuary 31st, 2019

Grant Support

  • MPD Clinical ConsortiumNational Cancer Institute2011
  • Clinical Trial: On 01910na In Patients With Refractory Lukemia Or MyelodysplastNational Center For Research Resources2009
  • MPD Clinical ConsortiumNational Cancer Institute2007–2009
  • MPD Clinical ConsortiumNational Cancer Institute2006
  • Cancer And Leukemia Group B--Mount SinaiNational Cancer Institute2001–2002

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Lewis Silverman, Dr. Lewis Silverman, MD, Dr. L Silverman, Dr. Lewis R Silverman